1. Home
  2. ANPA vs CNTX Comparison

ANPA vs CNTX Comparison

Compare ANPA & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rich Sparkle Holdings Limited Ordinary Shares

ANPA

Rich Sparkle Holdings Limited Ordinary Shares

N/A

Current Price

$1.16

Market Cap

47.0M

Sector

N/A

ML Signal

N/A

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

N/A

Current Price

$0.19

Market Cap

47.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ANPA
CNTX
Founded
2016
2015
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.0M
47.7M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
ANPA
CNTX
Price
$1.16
$0.19
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
★ $4.14
AVG Volume (30 Days)
18.1K
★ 1.2M
Earning Date
09-30-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 17.39
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.14
$0.18
52 Week High
$180.64
$3.62

Technical Indicators

Market Signals
Indicator
ANPA
CNTX
Relative Strength Index (RSI) 26.46 35.39
Support Level N/A $0.18
Resistance Level $2.18 $0.36
Average True Range (ATR) 0.10 0.02
MACD 0.02 0.00
Stochastic Oscillator 11.34 14.03

Price Performance

Historical Comparison
ANPA
CNTX

About ANPA Rich Sparkle Holdings Limited Ordinary Shares

Rich Sparkle Holdings Ltd is a holding company conducting its operations as a professional specialist in the provision of financial printing services such as printing, typesetting and translation, advisory services including Environmental, Social and Governance (ESG) and internal control reporting services and other services including standalone annual general meeting and extraordinary general meeting supporting service and other standalone services, through its sole operating subsidiary in Hong Kong. Its segments include Financial printing services such as printing, typesetting and translation, Advisory services including Environmental, Social and Governance Report and Other services.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: